|1.||Sadovskaya, Irina: 2 articles (02/2013 - 12/2007)|
|2.||Chokr, Ali: 2 articles (02/2013 - 12/2007)|
|3.||Watier, Denis: 2 articles (02/2013 - 12/2007)|
|4.||Leterme, Damien: 2 articles (02/2013 - 12/2007)|
|5.||van der Mei, H C: 2 articles (02/2004 - 06/2001)|
|6.||Busscher, H J: 2 articles (02/2004 - 06/2001)|
|7.||van Horn, J R: 2 articles (02/2004 - 06/2001)|
|8.||Chidiac, C: 1 article (09/2015)|
|9.||Calvet, B: 1 article (09/2015)|
|10.||Revest, M: 1 article (09/2015)|
07/01/2007 - "This study suggested that CWU could effectively enhance vancomycin release and antimicrobial efficacy of ALBC, which may be of clinical significance for treating prosthesis-related infections."
06/01/2009 - "Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA."
|2.||Bone Cements (Bone Glue)IBA
12/01/2006 - "The objective of this study was to investigate whether the viability of bacteria derived from patients with a prosthesis-related infection could be further decreased when antibiotic release from bone cements was combined with application of pulsed ultrasound. "
11/01/2008 - "The use of antibiotic loaded bone cements (ALBCs) has become a common clinical practice in the prevention and treatment of prosthesis-related infections. "
02/01/2004 - "This review presents the backgrounds of bone cements, prosthesis-related infection and antibiotic-loaded bone cements. "
12/01/2007 - "In conclusion, the encouraging results obtained in the animal study could not be readily applied for the diagnosis of staphylococcal orthopedic-prosthesis-related infections in humans, and PNAG does not seem to be an appropriate antigen for this purpose. "
12/01/2007 - "Potential use of poly-N-acetyl-beta-(1,6)-glucosamine as an antigen for diagnosis of staphylococcal orthopedic-prosthesis-related infections."
|4.||Anti-Bacterial Agents (Antibiotics)IBA
09/01/1994 - "Thus, failure of glycopeptide antibiotics to cure prosthesis-related infection is not due to poor penetration of drugs into biofilm but likely due to diminished antimicrobial effect on bacteria in the biofilm environment."
09/01/1994 - "To evaluate the adequacy of penetration of antibiotics into biofilm, a novel in vitro model for prosthesis-related infection was developed. "
01/01/1990 - "Clean-air systems in combination with perioperative systemic antibiotics reduce prosthesis-related infections from 3 or 4 per cent to a few per thousand. "
02/01/2012 - "Search terms included "prophylaxis," "antibiotics," "antimicrobials," "prosthetic devices," "prosthesis-related infections," "bacteremia," the names of the individual types of prosthetic devices, and the names of the individual procedures potentially inducing bacteremia. "
|5.||Rifampin (Rifampicin)FDA LinkGeneric
02/01/2000 - "Although numerous antimicrobial-coated surfaces have been suggested to guard against prosthesis-related infection, only a few, such as minocylcine plus rifampin, are clinically protective. "
12/01/1997 - "The early results with quinolones and rifampin for prosthesis-related infection are encouraging. "
|6.||Virulence Factors (Pathogenicity Factors)IBA
|8.||Proteins (Proteins, Gene)IBA
|10.||Minocycline (Cyclops)FDA LinkGeneric
|2.||Prostheses and Implants (Prosthesis)
|3.||Mammaplasty (Breast Reconstruction)
|4.||Penile Prosthesis (Penile Implants)